 |
|
|
19 January 2005
|
|
Emory Eye Center Offers New Vision Correction Procedure for Severe Myopia
|
|
For those people who have dealt with severe degrees of myopia yet have not been good candidates for surgeries such as LASIK, a new implant may provide them new hope -- and new vision.
The new Verisyse phakic intra-ocular lens implant can be inserted into an eye that still retains its own lens ("phakic"). In approving the new procedure, the FDA cited Ophtec studies-one of which was conducted at Emory Eye Center with Doyle Stulting, MD, PhD, as principal investigator-stating that after 3 years, 92% of the patients who received their lens had 20/40 or better vision, and 44% had 20/20 or better.
Insertion of the lens is a short (15-30 minutes) outpatient procedure, with a quick recovery time and no removal of tissue. An incision is made in the eye and the tiny lens is centered on the iris and directly over the pupil. The lens will remain in this location permanently, although it can easily be removed if necessary. Excellent visual acuity is achieved almost immediately after surgery. The Verisyse lens design has a long track record of success in Europe and has been safely implanted in more than 150,000 eyes worldwide.
|
|
|
 |
 |
|
Emory University's Woodruff Health Sciences Center is one of the nation's pre-eminent academic health centers, devoted to Making People Healthy through research, teaching, and patient care. It includes the Emory University School of Medicine, the Rollins School of Public Health, the Nell Hodgson Woodruff School of Nursing, and the Yerkes National Primate Research Center. Its clinical arm is Emory Healthcare, Georgia's largest and most comprehensive health care system, consisting of Emory University Hospital, Emory Crawford Long Hospital, Wesley Woods Center, The Emory Clinic, the Emory Children's Center, EHCA, LLC, Emory-Adventist Hospital, and other affiliates.
|
|
© Emory University 2021
|
|